<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40"><head><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=Generator content="Microsoft Word 12 (filtered medium)"><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Cambria;
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
h2
{mso-style-priority:9;
mso-style-link:"Heading 2 Char";
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:18.0pt;
font-family:"Times New Roman","serif";
font-weight:bold;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.Heading2Char
{mso-style-name:"Heading 2 Char";
mso-style-priority:9;
mso-style-link:"Heading 2";
font-family:"Cambria","serif";
color:#4F81BD;
font-weight:bold;}
span.gmail-field
{mso-style-name:gmail-field;}
span.EmailStyle20
{mso-style-type:personal-reply;
font-family:"Calibri","sans-serif";
color:#1F497D;}
.MsoChpDefault
{mso-style-type:export-only;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]--></head><body lang=EN-CA link=blue vlink=purple><div class=WordSection1><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Hi all:<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>See below for a few interesting articles relating to MRI use for PCa.<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Take care,<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'>Glen<o:p></o:p></span></p><p class=MsoNormal><span style='font-size:11.0pt;font-family:"Calibri","sans-serif";color:#1F497D'><o:p> </o:p></span></p><p class=MsoNormal><o:p> </o:p></p><div><h2 style='margin:0cm;margin-bottom:.0001pt;line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>recent articles related to prostate cancer 2019-06-16</span><span style='font-size:13.0pt;font-family:"Cambria","serif";color:#4F81BD'><o:p></o:p></span></h2><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> <o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> </span></b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> <o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Prostate cancer “super-active</span></b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> <o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> <o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>MRI scans to be trialled as test for prostate cancer </span></b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><a href="https://www.theguardian.com/society/2019/jun/09/mri-scans-to-be-trialled-as-test-for-prostate-cancer">https://www.theguardian.com/society/2019/jun/09/mri-scans-to-be-trialled-as-test-for-prostate-cancer</a><o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> <o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span class=gmail-field><b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Combined MRI, US-guided biopsy detects more prostate cancers</span></b></span><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><a href="https://www.healthimaging.com/topics/oncology-imaging/mri-us-biopsy-detects-more-prostate-cancer">https://www.healthimaging.com/topics/oncology-imaging/mri-us-biopsy-detects-more-prostate-cancer</a><o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> <o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>What Is the Optimal MRI-Guided Biopsy Approach in Prostate Cancer? </span></b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><a href="https://www.cancernetwork.com/prostate-cancer/what-optimal-mri-guided-biopsy-approach-prostate-cancer">https://www.cancernetwork.com/prostate-cancer/what-optimal-mri-guided-biopsy-approach-prostate-cancer</a><o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> <o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> <o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'>Quick Take: Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic Outcomes</span></b><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'><a href="https://www.2minutemedicine.com/quick-take-image-guided-irreversible-electroporation-of-localized-prostate-cancer-functional-and-oncologic-outcomes/">https://www.2minutemedicine.com/quick-take-image-guided-irreversible-electroporation-of-localized-prostate-cancer-functional-and-oncologic-outcomes/</a><o:p></o:p></span></p><p class=MsoNormal style='line-height:12.0pt'><span style='font-size:11.0pt;font-family:"Calibri","sans-serif"'> <o:p></o:p></span></p></div></div></body></html>